THERESA:PFS by Investigator Assessment
> 2
nd
line
Median follow-up: TPC, 6.5 months; T-DM1, 7.2 months.
Unstratified HR=0.521 (
P
<0.0001).
198
120
62
28
13
6
1
0
404
334
241
114
66
27
12
0
TPC
T-DM1
No. at risk:
Time (months)
14
12
10
8
6
4
2
0.0
0.2
0.4
0.6
0.8
1.0
0
Proportion progression-free
TPC
(n=198)
T-DM1
(n=404)
Median (months)
3.3
6.2
No. of events
129
219
Stratified HR=0.528 (95% CI, 0.422, 0.661)
P
<0.0001
Krop I, Lancet Oncol 2014
